Physician profile
Spencer Holover
NPI 1952346157
$4,213.87
in general payments reported to CMS, 2019-2025
19 companies · $859 in 2025
The $859 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,488 · 2021: $1,017 · 2022: $24.29 · 2023: $519 · 2024: $306 · 2025: $859.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067 · Travel and Lodging: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,066.70 |
| Travel and Lodging | $617.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,351.89 | 2021-2025 | Ligasure, Signia |
| Intra-Sana Laboratories | $1,186.18 | 2021-2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Intuitive Surgical, INC. | $951.41 | 2019 | |
| Covidien LP | $328.28 | 2019 | |
| Novo Nordisk INC | $47.90 | 2019 | |
| Olympus America INC. | $42.64 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $37.68 | 2023 | Caldolor |
| Nalpropion Pharmaceuticals LLC | $31.66 | 2019 | |
| Currax Pharmaceuticals LLC | $31.10 | 2019-2021 | |
| Boston Scientific Corporation | $29.42 | 2019 | |
| Eisai INC. | $29.12 | 2019 | |
| Baxter Healthcare | $27.94 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Standard Bariatrics, INC. | $24.29 | 2022 | |
| Redhill Biopharma INC. | $23.47 | 2023 | Talicia |
| Endo Pharmaceuticals INC. | $22.78 | 2023 | Nascobal |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $20.16 | 2019 | |
| Shire North American Group INC | $14.06 | 2019 | |
| Heron Therapeutics, INC. | $13.89 | 2023 | Zynrelef |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$58,496.64 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Spencer Holover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.